alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages.

PubWeight™: 2.77‹?› | Rank: Top 1%

🔗 View Article (PMID 11285265)

Published in J Biol Chem on April 02, 2001

Authors

A Koschak1, D Reimer, I Huber, M Grabner, H Glossmann, J Engel, J Striessnig

Author Affiliations

1: Institut für Biochemische Pharmakologie, Peter-Mayr-Strasse 1, A-6020 Innsbruck, Austria.

Articles citing this

(truncated to the top 100)

Calcium and arrhythmogenesis. Physiol Rev (2007) 2.76

Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet (2013) 2.63

Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A (2003) 2.60

Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci (2009) 2.35

Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci (2010) 2.00

The L-Type voltage-gated calcium channel Cav1.3 mediates consolidation, but not extinction, of contextually conditioned fear in mice. Learn Mem (2006) 1.87

Sodium and calcium currents shape action potentials in immature mouse inner hair cells. J Physiol (2003) 1.75

Structure and function of the hair cell ribbon synapse. J Membr Biol (2006) 1.73

Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease. Nat Neurosci (2012) 1.70

Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels. J Clin Invest (2004) 1.69

Mechanisms underlying the temporal precision of sound coding at the inner hair cell ribbon synapse. J Physiol (2006) 1.46

Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia (2009) 1.46

Ca2+-binding proteins tune Ca2+-feedback to Cav1.3 channels in mouse auditory hair cells. J Physiol (2007) 1.45

The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev (2015) 1.38

Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J Biol Chem (2011) 1.37

Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci (2009) 1.34

Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. Cell Calcium (2010) 1.34

Biophysical properties of CaV1.3 calcium channels in gerbil inner hair cells. J Physiol (2008) 1.34

Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. J Biol Chem (2008) 1.32

The extracellular matrix molecule hyaluronic acid regulates hippocampal synaptic plasticity by modulating postsynaptic L-type Ca(2+) channels. Neuron (2010) 1.31

MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. Mol Cell Neurosci (2010) 1.30

Spontaneous voltage oscillations in striatal projection neurons in a rat corticostriatal slice. J Physiol (2003) 1.29

Cav1.3 (alpha1D) Ca2+ currents in neonatal outer hair cells of mice. J Physiol (2003) 1.29

Increased phosphorylation of the neuronal L-type Ca(2+) channel Ca(v)1.2 during aging. Proc Natl Acad Sci U S A (2003) 1.28

Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons. J Neurosci (2009) 1.27

Hair cell ribbon synapses. Cell Tissue Res (2006) 1.25

The molecular architecture of ribbon presynaptic terminals. Mol Neurobiol (2009) 1.24

Biophysical and pharmacological characterization of voltage-gated calcium currents in turtle auditory hair cells. J Physiol (2003) 1.22

The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease. Neuroscience (2011) 1.20

Ca2+-dependent modulation of voltage-gated Ca2+ channels. Biochim Biophys Acta (2011) 1.16

The origins of oxidant stress in Parkinson's disease and therapeutic strategies. Antioxid Redox Signal (2010) 1.16

Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. Eur J Neurosci (2006) 1.15

The electrophysiological properties of spontaneously beating pacemaker cells isolated from mouse sinoatrial node. J Physiol (2003) 1.13

L-type Ca2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment. J Neurosci (2004) 1.12

Apical GLUT2 and Cav1.3: regulation of rat intestinal glucose and calcium absorption. J Physiol (2007) 1.12

Critical role for the beta regulatory subunits of Cav channels in T lymphocyte function. Proc Natl Acad Sci U S A (2006) 1.11

Functional characterization of alternative splicing in the C terminus of L-type CaV1.3 channels. J Biol Chem (2011) 1.11

Characterization of voltage-dependent sodium and calcium channels in mouse pancreatic A- and B-cells. J Physiol (2006) 1.09

Ca2+-dependent facilitation of Cav1.3 Ca2+ channels by densin and Ca2+/calmodulin-dependent protein kinase II. J Neurosci (2010) 1.08

Assembly and disassembly of a retinal cholinergic network. Vis Neurosci (2011) 1.08

Ca2+-independent activation of BKCa channels at negative potentials in mammalian inner hair cells. J Physiol (2005) 1.06

The impact of splice isoforms on voltage-gated calcium channel alpha1 subunits. J Physiol (2003) 1.06

L-type Ca(2+) channels in heart and brain. Wiley Interdiscip Rev Membr Transp Signal (2014) 1.06

Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J Clin Invest (2012) 1.05

Ca2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease. Mol Vis (2007) 1.04

Cardiac-type EC-coupling in dysgenic myotubes restored with Ca2+ channel subunit isoforms alpha1C and alpha1D does not correlate with current density. Biophys J (2003) 1.04

Alternative splicing: functional diversity among voltage-gated calcium channels and behavioral consequences. Biochim Biophys Acta (2012) 1.04

Impaired Ca2+ homeostasis is associated with atrial fibrillation in the alpha1D L-type Ca2+ channel KO mouse. Am J Physiol Heart Circ Physiol (2008) 1.02

Intracellular calcium store filling by an L-type calcium current in the basolateral amygdala at subthreshold membrane potentials. J Physiol (2004) 1.02

Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein. J Biol Chem (2011) 1.01

Effects of permeant ion concentrations on the gating of L-type Ca2+ channels in hair cells. Biophys J (2003) 1.00

Molecular and biophysical mechanisms of Ca2+ sparklets in smooth muscle. J Mol Cell Cardiol (2009) 1.00

Molecular basis of the T- and L-type Ca2+ currents in canine Purkinje fibres. J Physiol (2007) 1.00

Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development. PLoS One (2010) 0.99

Physiological phenotype and vulnerability in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 0.98

Expression and roles of Cav1.3 (α1D) L-type Ca²+ channel in atrioventricular node automaticity. J Mol Cell Cardiol (2010) 0.98

Molecular pharmacology of high voltage-activated calcium channels. J Bioenerg Biomembr (2003) 0.97

Molecular basis of R-type calcium channels in central amygdala neurons of the mouse. Proc Natl Acad Sci U S A (2002) 0.97

Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.96

CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biol Psychiatry (2014) 0.92

Dopamine inhibits N-type channels in visceral afferents to reduce synaptic transmitter release under normoxic and chronic intermittent hypoxic conditions. J Neurophysiol (2009) 0.92

Role of calcium channels in congenital heart block. Scand J Immunol (2010) 0.92

Psychostimulants, L-type calcium channels, kinases, and phosphatases. Neuroscientist (2005) 0.91

Interaction of bestrophin-1 and Ca2+ channel β-subunits: identification of new binding domains on the bestrophin-1 C-terminus. PLoS One (2011) 0.91

Arachidonic acid inhibition of L-type calcium (CaV1.3b) channels varies with accessory CaVbeta subunits. J Gen Physiol (2009) 0.91

Emerging roles of L-type voltage-gated and other calcium channels in T lymphocytes. Front Immunol (2013) 0.90

Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol (2015) 0.89

Harmonin enhances voltage-dependent facilitation of Cav1.3 channels and synchronous exocytosis in mouse inner hair cells. J Physiol (2013) 0.88

T-type calcium channels and vascular function: the new kid on the block? J Physiol (2010) 0.87

Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node. J Physiol (2012) 0.87

Developmental alterations in the biophysical properties of Ca(v) 1.3 Ca(2+) channels in mouse inner hair cells. Channels (Austin) (2013) 0.87

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. Nat Commun (2014) 0.87

Maturation of rat cerebellar Purkinje cells reveals an atypical Ca2+ channel current that is inhibited by omega-agatoxin IVA and the dihydropyridine (-)-(S)-Bay K8644. J Physiol (2006) 0.86

Complex distribution patterns of voltage-gated calcium channel α-subunits in the spiral ganglion. Hear Res (2011) 0.86

C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca(2+) channels. Biophys J (2014) 0.86

Calcium channels: unanswered questions. J Bioenerg Biomembr (2003) 0.86

Functional role of voltage gated Ca(2+) channels in heart automaticity. Front Physiol (2015) 0.86

PDE type-4 inhibition increases L-type Ca(2+) currents, action potential firing, and quantal size of exocytosis in mouse chromaffin cells. Pflugers Arch (2008) 0.85

Are Ca(v)1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage. Channels (Austin) (2011) 0.85

Synaptic release at mammalian bipolar cell terminals. Vis Neurosci (2011) 0.85

Design of mutant beta2 subunits as decoy molecules to reduce the expression of functional Ca2+ channels in cardiac cells. J Pharmacol Exp Ther (2008) 0.85

Cav1.3 Channels as Key Regulators of Neuron-Like Firings and Catecholamine Release in Chromaffin Cells. Curr Mol Pharmacol (2015) 0.84

Diminished vision in healthy aging is associated with increased retinal L-type voltage gated calcium channel ion influx. PLoS One (2013) 0.84

Silencing of Cav1.2 gene in neonatal cardiomyocytes by lentiviral delivered shRNA. Biochem Biophys Res Commun (2009) 0.83

Voltage-dependent amplification of synaptic inputs in respiratory motoneurones. J Physiol (2012) 0.83

Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.83

Regulation of gene transcription by voltage-gated L-type calcium channel, Cav1.3. J Biol Chem (2014) 0.82

Calcium signaling in the cochlea - Molecular mechanisms and physiopathological implications. Cell Commun Signal (2012) 0.82

Perinatal and postnatal expression of Cav1.3 α1D Ca²⁺ channel in the rat heart. Pediatr Res (2011) 0.81

Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets? Curr Mol Pharmacol (2015) 0.81

Alcohol Withdrawal-Induced Seizure Susceptibility is Associated with an Upregulation of CaV1.3 Channels in the Rat Inferior Colliculus. Int J Neuropsychopharmacol (2015) 0.81

From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms. Neurotherapeutics (2017) 0.80

Dynamic interplay of excitatory and inhibitory coupling modes of neuronal L-type calcium channels. Am J Physiol Cell Physiol (2011) 0.80

Equal sensitivity of Cav1.2 and Cav1.3 channels to the opposing modulations of PKA and PKG in mouse chromaffin cells. J Physiol (2012) 0.80

Inhibition of recombinant L-type voltage-gated calcium channels by positive allosteric modulators of GABAA receptors. J Pharmacol Exp Ther (2011) 0.80

Expression profile of voltage-dependent Ca2+ channel subunits in the human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol (2008) 0.80

The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases. Curr Neuropharmacol (2013) 0.80

Impact of gating modulation in CaV1.3 L-type calcium channels. Channels (Austin) (2010) 0.79

Ionic currents in intimal cultured synoviocytes from the rabbit. Am J Physiol Cell Physiol (2010) 0.79

An improved targeted cAMP sensor to study the regulation of adenylyl cyclase 8 by Ca2+ entry through voltage-gated channels. PLoS One (2013) 0.79

Articles by these authors

Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol (1983) 11.06

Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res (1984) 6.56

Phylogenetic analysis and in situ identification of bacteria in activated sludge. Appl Environ Microbiol (1997) 5.61

Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat. J Biol Chem (1971) 5.25

Detection and in situ identification of representatives of a widely distributed new bacterial phylum. FEMS Microbiol Lett (1997) 5.20

Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08

The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion. EMBO J (1987) 4.00

Hippocampal and entorhinal cortex high-frequency oscillations (100--500 Hz) in human epileptic brain and in kainic acid--treated rats with chronic seizures. Epilepsia (1999) 3.96

High-frequency oscillations in human brain. Hippocampus (1999) 3.89

Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate. Methods Enzymol (1974) 3.50

Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A (1996) 3.39

A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J (1999) 3.20

Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J (1990) 3.16

Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix. J Mol Biol (1981) 3.15

Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia (2001) 2.90

The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel? Science (1996) 2.87

A new nomenclature for the laminins. Matrix Biol (1994) 2.82

The ARF1 GTPase-activating protein: zinc finger motif and Golgi complex localization. Science (1995) 2.72

Kinetics of the cooperative association of actin to actin filaments. Biophys Chem (1975) 2.55

Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun (1995) 2.48

Protease resistance and conformation of laminin. Eur J Biochem (1982) 2.47

Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note. J Neurosurg (1999) 2.46

Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science (1995) 2.38

Electron-microscopical approach to a structural model of intima collagen. Biochem J (1983) 2.32

Chronic epileptogenesis requires development of a network of pathologically interconnected neuron clusters: a hypothesis. Epilepsia (2000) 2.31

CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23

Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding. Eur J Biochem (1994) 2.23

Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23

Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem (1994) 2.22

Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22

7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem (1980) 2.19

Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med (1999) 2.18

Laminin-nidogen complex. Extraction with chelating agents and structural characterization. Eur J Biochem (1987) 2.15

Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem (2000) 2.09

Foreign body ingestion: review and suggested guidelines for management. Endoscopy (1987) 2.08

BBID: the biological biochemical image database. Bioinformatics (2000) 2.07

Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains. EMBO J (1996) 2.05

Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis (2004) 2.02

Single amino acid substitutions in one Ca2+ binding site of uvomorulin abolish the adhesive function. Cell (1990) 1.98

Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization. Eur J Biochem (1980) 1.96

Stabilization of short collagen-like triple helices by protein engineering. J Mol Biol (2001) 1.88

A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care (1992) 1.84

Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci (1992) 1.84

Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection. Epilepsia (1999) 1.83

Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis (2006) 1.82

Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol (1995) 1.82

Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophys J (2001) 1.79

Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol (1980) 1.78

Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane. Eur J Biochem (1984) 1.77

Domains of laminin with growth-factor activity. Cell (1989) 1.75

Acquiring simultaneous EEG and functional MRI. Clin Neurophysiol (2000) 1.75

Subunit structure and assembly of the globular domain of basement-membrane collagen type IV. Eur J Biochem (1984) 1.74

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod (2000) 1.74

Plasma membrane protein subunit composition. A comparative study by discontinuous electrophoresis in sodium dodecyl sulfate. J Biol Chem (1971) 1.74

Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol (1982) 1.73

Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory end points. Am J Physiol (1995) 1.72

Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci (1996) 1.71

Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsy. Neurology (2005) 1.69

Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci (1998) 1.69

Evidence for coiled-coil alpha-helical regions in the long arm of laminin. EMBO J (1985) 1.68

Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61

D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res (1996) 1.61

Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebacterium species in the laboratory management of diphtheria-associated bacteria. Euro Surveill (2010) 1.60

Assay for calcium channels. Methods Enzymol (1985) 1.60

[The effect of needle type and immobilization on postspinal headache]. Anaesthesist (1997) 1.59

FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology (2008) 1.59

Localization of flexible sites in thread-like molecules from electron micrographs. Comparison of interstitial, basement membrane and intima collagens. J Mol Biol (1984) 1.59

Saccharomyces cerevisiae Gcs1 is an ADP-ribosylation factor GTPase-activating protein. Proc Natl Acad Sci U S A (1996) 1.57

Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. J Mol Biol (2003) 1.56

Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J Mol Biol (1988) 1.55

7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest (2001) 1.55

An autonomous folding unit mediates the assembly of two-stranded coiled coils. Proc Natl Acad Sci U S A (1998) 1.54

Calcium binding and homoassociation of E-cadherin domains. Biochemistry (1997) 1.54

Exchange of ADP, ATP and 1: N6-ethenoadenosine 5'-triphosphate at G-actin. Equilibrium and kinetics. Eur J Biochem (1979) 1.53

A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm away. J Biol Chem (1988) 1.51

Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci U S A (1998) 1.49

Electron microscopy and other physical methods for the characterization of extracellular matrix components: laminin, fibronectin, collagen IV, collagen VI, and proteoglycans. Methods Enzymol (1987) 1.48

Finally, a randomized, controlled trial of epilepsy surgery. N Engl J Med (2001) 1.47

Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat Genet (1999) 1.47

Crystal structure of a naturally occurring parallel right-handed coiled coil tetramer. Nat Struct Biol (2000) 1.46

Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron (1996) 1.46

Homophilic adhesion by cadherins. Curr Opin Struct Biol (1999) 1.46

Current modulation and membrane targeting of the calcium channel alpha1C subunit are independent functions of the beta subunit. J Physiol (1999) 1.45

Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem (1998) 1.44

Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol (1990) 1.44

Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J (1998) 1.43

Magnetic resonance imaging in intractable partial epilepsy: correlative studies. Ann Neurol (1986) 1.43

Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol (1982) 1.43

Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect Immun (1997) 1.42

Extended and globular protein domains in cartilage proteoglycans. Biochem J (1987) 1.42

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis (2001) 1.41

Generic substitutions for antiepileptic drugs. Neurology (1990) 1.41

Activation of ADP-ribosylation factor 1 GTPase-activating protein by phosphatidylcholine-derived diacylglycerols. J Biol Chem (1997) 1.40

Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan. EMBO J (1992) 1.38